Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Tumor Boards in Clinical Practice.

Trends in cancer - 1 Sept 2020

Luchini Claudio, Lawlor Rita T, Milella Michele, Scarpa Aldo

Abstract excerpt

Next-generation sequencing (NGS) application in clinical practice requires the implementation of molecular tumor boards (MTBs). Starting from a systematic review of literature, we discuss the MTB-related key points: MTB aims and composition, types of tumors to discuss, types of molecular analyses, methods for classifying actionability, appropriate turnaround time, and cost management.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Clinical Decision-Making
Share to Consensus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to Medical Oncology

Share to Molecular Targeted Therapy

Share to Patient Care Team

Share to Precision Medicine

Source

Identifiers

PMID: 32517959
DOI: 10.1016/j.trecan.2020.05.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Tumor Boards in Clinical Practice.PMID 32517959Read ↗

Molecular Tumor Boards: Realizing Precision Oncology Therapy.Semantic proximity Read ↗

Precision oncology: separating the wheat from the chaffSemantic proximity Read ↗

The molecular tumor board—a key element of precision oncologySemantic proximity Read ↗

Next-Generation Sequencing in Oncology—A Guiding Compass for Targeted Therapy and Emerging ApplicationsSemantic proximity Read ↗

Current practices and guidelines for clinical next-generation sequencing oncology testing.Semantic proximity Read ↗

How to read a next-generation sequencing report—what oncologists need to knowSemantic proximity Read ↗

Next-generation sequencing: a change of paradigm in molecular diagnostic validation.Semantic proximity Read ↗

Feasibility of whole‐genome sequencing‐based tumor diagnostics in routine pathology practiceSemantic proximity Read ↗

Cancer treatment comes to age: from one-size-fits-all to next-generation sequencing (NGS) technologiesSemantic proximity Read ↗

Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and cliniciansSemantic proximity Read ↗

Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL.Semantic proximity Read ↗

Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.